Form 483

CoreRX Inc. Form 483, 2026-02-26

FDA issued a Form 483 to CoreRX Inc. on 2026-02-26 with 7 public-safe observations.

483· Form 483 issuedHuman Drugs7 observations

CoreRX Inc. · Clearwater, United States · Issued February 26, 2026

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

26 Feb 2026
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Nicole E Knowlton, Kayla V Sprague, Tammy T Brown

26 Feb 2026
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Nicole E Knowlton, Kayla V Sprague, Tammy T Brown

26 Feb 2026
21 CFR 211.52

Washing and toilet facilities are deficient

Cited by Nicole E Knowlton, Kayla V Sprague, Tammy T Brown

26 Feb 2026
21 CFR 211.58

Buildings not maintained in good state of repair

Cited by Nicole E Knowlton, Kayla V Sprague, Tammy T Brown

26 Feb 2026
21 CFR 211.68(b)

Computer control of master formula records

Cited by Nicole E Knowlton, Kayla V Sprague, Tammy T Brown

Inspected site

CICoreRX Inc.Clearwater, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.113(a)Cited across public-safe Form 483 observations1x
21 CFR 211.52Cited across public-safe Form 483 observations1x
21 CFR 211.58Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x
21 CFR 211.84(b)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 7 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere